Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
If you listened to my advice and bought in at 15p, you could’ve sold today for 18% profit.
The monumental ACTIV2 results have been released and the share price has gone up by 6.25% to just over 17p.
Congrats everyone on the fantastic news and the 6.25% increase in share price. Where is the party going to be?
Grown men and women desperately clinging on to a pipedream when they know that the likelihood of it happening has just reduced from 15% to 2%
Even when that dream is reduced further still to 0.2% they’ll be furiously typing on this forum talking about platform trials (which are not going to happen) and the science behind interferons.
Two possibilities:
1. Such people work for the company and are paid to ramp. The company don’t exactly have much to do each day except speak to governments or pharma companies begging for a free trial, there is no trial.
2. They’re here for a laugh. Just having a laugh and haven’t been invested at all. They see the mad Synairgen zealots, this devote band of people who are clinging on to a 2% chance of success, against any logical reason.
Einstein said the definition of stupidity is to do the same thing over and over again, expecting a different outcome.
Marsden has been CEO for close to 20 years, in those 20 years this drug has failed to commercialise. After the biggest embarrassment in this company’s history and the biggest let down of 2022 in the entire pharma world, the same Synairgen zealots on this forum still have that hope and belief that Marsden is going to somehow get this drug to market very soon.
The delusion is real
Trade this turkey
Enough cash (if just using it for fat salaries and operational costs) to last until Q4 2023.
Not enough cash for a P3 trial to get SNG001 over the line.
Fixed it for you.
Perhaps Marsden can keep trying at ‘haste’ to find a PT until Q4 2023 and then retire with a very fat pension?
Opinions welcome.
My price target was wedged today, so I’m actually rather pleased. I have now bought in again, I think there could be an upside over the next couple of months before it becomes apparent that a new fund raise will have to be made in order to finance a future COPD trial.
Manifesto, are you Brooke Clark, the Synairgen communications officer?
She is completely silent and has absolutely nothing to do all day, so perhaps you are her, typing away on forums with a positive slant on the company, remaining bullish and ramping the stock. All despite what looks like a horrendous six months ahead which will culminate in a further fund raise to avoid bankruptcy.
Many fat salaries to pay, including Marsden’s own salary and bonus. He must be delighted with the new tax cuts introduced by your new prime minister Truss.
But how long can Synairgen keep going with just £18m in the bank?
It’s not enough to fund their own trial, explaining why they are desperately trying to find free trials to join, to no avail in eight months.
Could the prospect of a new fund raise and a dilution of the shares become very real?
Either dilution or bust? Marsden could sit it out for the next two years whilst Truss is in power, taking his fat salary and bonus, perhaps enough to retire on now?
There we have it.
Despite the rampers on here best efforts to try and con people to buy in to this useless company, Drew’s price target of 15-18p is firmly reached.
As I wrote before, this stock is a turkey.
Buy in now for the speculative gamble and you might gain 100% over the next few months.
Why don’t long term holders get it in to their thick skulls that this company is not getting anything to market for the next three years at least, if at all.
Perhaps this will end the delusion?
Of course it won’t. The usual mob will be here saying ‘any day now, any day now, Drew made a post therefore the price must go up now’.
Advice = buy in now that the price target of 15-18p has been firmly reached. Hold for a long term speculative punt.
By long term, I mean five years.
Is the delusion bubble finally burst with the rampers?
Of course not hehehe. See you back here throughout the day to talk about how STRIVE and Marsden are planning something special.
To all those who doubled down at 22p, thinking they were lowering their average, unfortunately you got burnt yet again by this company.
At some stage you have to actually get annoyed with the company and the management of the company as opposed to other people on the message boards.
15-18p target price reached.
Buy in the 18’s.
With positive long covid data, this should go in to the 30’s.
Sell.
Then put short on.
Buy back when SP is in low 20’s again.
The company have had 8 months to partner with someone or get on a platform trial. The cashburn is real, they don’t know what they’re doing.
Use this stock to trade. With the long covid data being revealed in conference next month, some good news should be released in October.
Sell on the news and dump your shares after that.
Long term, zero prospects until the drug is on another phase 3 trial. Zero chance of coming to market until phase 3 success.
Synairgen aimed (extremely poorly), took their shot (SPRINTER) and missed in an embarrassing fashion.
Trade this turkey.
We breached nicely in to the 18p range today, as predicted.
Despite predicting further downward movement until any news, the 18’s represents a fair value to make a starting purchase of shares in this company.
15-18p range was the target price and this was reached today.
With an upcoming conference to report Long Covid data in October, this stock can yield a potential 100% upside over the next month.
My advice, buy in now, sell on the news.
The company do not have the cash runway to finance their own trial, hence the need for this company to find partners or platform trials. I don’t see it happening, they’ve had 8 months already now and zero news. There is no interest there, sadly they took aim, fired their shot and missed with the SPRINTER trial. Still, a potential short term 100% gain coming up with long covid data to be revealed.
Should long covid data be inadequate, expect price to go below 15p and a future fund raise to be necessary in order for this research company to continue.
Various rampers on this forum have been repeatedly talking of STRIVE. That Synairgen will be included in a new US trial. They have been saying ‘any day now’ for the last 4 months. Yet so far, zero news.
We should continue to see some nice negative movement of the SP. We reached 19.01 today and I believe will go in to the 18’s over the next week or so.
As I predicted 15 to 18p will be the time to invest.
Then hold out for the conference in October. Sell on the news. Then put on a shirt because the SP will come down again.
Buy in price should be low 19’s and 18’s, with a possible low of 15p before any news.
STRIVE absolutely nowhere to be seen for the last 4 months.
Queue ‘Andy B is here, therefore STRIVE must be taking place soon’. Ahem, they were saying that 4 months ago hehehehehehe ;)
Soon it’s time to buy in again.
Then sell on the news.
Then put your short on.
Business of making money :)
Drew
To clarify, WHO says that the end of the pandemic is in site. Covid mutating to a regular flu like illness which won’t need special medication.
However, as mentioned in the first post, SNG could be a long term speculative punt if you are prepared to buy in low and then double down if/when they offer a fund raise which will dilute the existing shares (most like in a year, as they don’t seem to be willing to fund a trial themselves with the money they have, they will need to raise funds for a trial or essentially they have no value at all as they are just a research company that aren’t even doing any research), simply leaching off shareholders cash.
If you want to take the punt for the next pandemic (5-15 years) then 15-18p can be your buy in price.
Double down and lower average if they do the fund raise in a year or so and price travels to below 10p.
Then hold until next pandemic.
Even if Synairgen can get a phase 2 trial done when the next pandemic is here, SP will rocket 10 times, as it did during the covid pandemic. Then sell, as this company can’t get anything to market.
Wait for SP to go below 18 first.
Thank me later :)
As predicted, SP falling down. 8% further down so far today.
SP heading to 15-18p. Time to buy in at the price if buying in for the first time.
Then if a new fund raise is offered and shares diluted, price will fall below 10, time to lower average and then hold for the long term speculative punt.
Once again, AndyBe is correct ;)
How am I wrong? Was 19p earlier.
Of course fluctuations are going to occur daily.
There is only one way this SP is going. Down.
Was 40p two months ago. Then fell to 30p, now Synairgen is breaching 20p.
15p incoming.
People can like your comment as much as they want. The bottom line is that at the moment with no news and no trials this company is a pile of sh11te.
Are people on here still latching on to hearsay?
There is no news. There are no trials. The WHO says the end of the pandemic is in sight. Face it, your money is gone.
As for ‘positive news must be coming soon’. Well I’ve been saying that the price will keep going down for the last three months. Every time I say this, some muppet says ‘AndyB is here, there must be good news coming’, but instead NO NEWS HAS COME.
It’s pathetic, the company is a university spin off, they don’t even have another trial sorted. If you followed small biotech you would know that most biotech companies would have a trial sorted within 8 months.
Advice stays the same. Wait until 18p is breached and then invest. Then if there is a new fund raise, invest at under 10p. Then hold for 10-20 years for the speculative gamble.
As per the title.
Unfortunately Synairgen couldn’t stump up the goods this time round. But there will be other virus’ and pandemics in the future years to come.
https://www.reuters.com/business/healthcare-pharmaceuticals/who-chief-says-end-sight-covid-19-pandemic-2022-09-14/
Some good negative movement today, reaching just above 19.
19p is the next target to breach, if we can penetrate below 19p then this will slide down to the 15’s.
As explained in previous threads, for the long term speculative punt, put half in at the 15-18p range and then lower your average if the SP sinks to 6p after a fund raise.
Then simply hold for the long term punt.